FDA Inspection 921555 — Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. on Mar 20, 2015 in Fuzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 20, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fuzhou (China)